| abstract |
The present invention relates to novel pharmaceutical uses for compounds that exhibit activity as nitric oxide synthase (NOS) inhibitors. In particular, it is (a) alone or in mixture with other active substances for the treatment of psoriasis; (b) in admixture with anti-inflammatory agents for the treatment of inflammatory diseases; (c) in admixture with anesthetic analgesics (eg, opiates such as morphine or demerol) for the treatment of pain; (d) alone or in admixture with other active substances to enhance cognition; (E) the use of NOS inhibitors, in particular selective neuronal NOS (N-NOS) inhibitors, used alone or in admixture with other active substances for the treatment of sleep diseases such as apnea, sleep attacks and insomnia. |